tm logo
KEPZAVYQ
Live/Registered
REGISTERED

on 15 Oct 2024

Last Applicant/ Owned by

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

97541157 filed on 09th Aug 2022

Registration Number

7532813 registered on 15th Oct 2024

in the Principal Register

Correspondent Address

Elizabeth K. Rucki

Elizabeth K. Rucki GSK

LEGAL BRAND PROTECTION

DURHAM, NC 27701

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

KEPZAVYQ

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respira Read More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97541157

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84187262

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Oct 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
15th Oct 2024REGISTERED-PRINCIPAL REGISTER
30th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30th Jul 2024PUBLISHED FOR OPPOSITION
10th Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24th Jun 2024CASE RETURNED TO EXAMINATION
24th Jun 2024NOTICE OF ALLOWANCE CANCELLED
12th Jun 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
12th Jun 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
10th Jun 2024ASSIGNED TO PETITION STAFF